Annual Current Assets
$2.98 B
+$290.45 M+10.79%
31 December 2023
Summary:
Alnylam Pharmaceuticals annual total current assets is currently $2.98 billion, with the most recent change of +$290.45 million (+10.79%) on 31 December 2023. During the last 3 years, it has risen by +$367.92 million (+14.07%). ALNY annual current assets is now at all-time high.ALNY Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$3.36 B
+$182.57 M+5.75%
30 September 2024
Summary:
Alnylam Pharmaceuticals quarterly total current assets is currently $3.36 billion, with the most recent change of +$182.57 million (+5.75%) on 30 September 2024. Over the past year, it has increased by +$369.97 million (+12.39%). ALNY quarterly current assets is now at all-time high.ALNY Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.8% | +12.4% |
| 3 y3 years | +14.1% | +25.4% |
| 5 y5 years | +148.4% | +76.9% |
ALNY Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +14.1% | at high | +35.8% |
| 5 y | 5 years | at high | +148.4% | at high | +111.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Alnylam Pharmaceuticals Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.36 B(+5.8%) |
| June 2024 | - | $3.17 B(+6.2%) |
| Mar 2024 | - | $2.99 B(+0.2%) |
| Dec 2023 | $847.18 M(-0.8%) | $2.98 B(-0.1%) |
| Sept 2023 | - | $2.99 B(+18.3%) |
| June 2023 | - | $2.52 B(-0.7%) |
| Mar 2023 | - | $2.54 B(-5.6%) |
| Dec 2022 | $854.11 M(+2.3%) | $2.69 B(+0.1%) |
| Sept 2022 | - | $2.69 B(+8.9%) |
| June 2022 | - | $2.47 B(-4.6%) |
| Mar 2022 | - | $2.59 B(-7.8%) |
| Dec 2021 | $834.73 M(+5.4%) | $2.81 B(+5.0%) |
| Sept 2021 | - | $2.68 B(-1.8%) |
| June 2021 | - | $2.73 B(+38.3%) |
| Mar 2021 | - | $1.97 B(-24.7%) |
| Dec 2020 | $792.28 M(+16.6%) | $2.61 B(+27.3%) |
| Sept 2020 | - | $2.05 B(-4.9%) |
| June 2020 | - | $2.16 B(+36.3%) |
| Mar 2020 | - | $1.58 B(-7.6%) |
| Dec 2019 | $679.27 M(+81.6%) | $1.72 B(-9.6%) |
| Sept 2019 | - | $1.90 B(-8.1%) |
| June 2019 | - | $2.06 B(+48.3%) |
| Mar 2019 | - | $1.39 B(+15.9%) |
| Dec 2018 | $374.11 M(+62.7%) | $1.20 B(-10.5%) |
| Sept 2018 | - | $1.34 B(-10.7%) |
| June 2018 | - | $1.50 B(-10.8%) |
| Mar 2018 | - | $1.69 B(-4.5%) |
| Dec 2017 | $229.99 M(-61.1%) | $1.76 B(+77.7%) |
| Sept 2017 | - | $993.37 M(+3.4%) |
| June 2017 | - | $960.71 M(+60.9%) |
| Mar 2017 | - | $597.19 M(-11.1%) |
| Dec 2016 | $590.93 M(+110.2%) | $671.88 M(-10.1%) |
| Sept 2016 | - | $747.56 M(-15.8%) |
| June 2016 | - | $888.07 M(-15.4%) |
| Mar 2016 | - | $1.05 B(-5.0%) |
| Dec 2015 | $281.12 M(-15.6%) | $1.11 B(+6.1%) |
| Sept 2015 | - | $1.04 B(+1.2%) |
| June 2015 | - | $1.03 B(-5.6%) |
| Mar 2015 | - | $1.09 B(+46.1%) |
| Dec 2014 | $333.23 M | $746.37 M(+16.1%) |
| Sept 2014 | - | $643.02 M(-3.3%) |
| June 2014 | - | $665.12 M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $674.06 M(+165.3%) |
| Dec 2013 | $166.50 M(+2.8%) | $254.03 M(+27.5%) |
| Sept 2013 | - | $199.16 M(-7.1%) |
| June 2013 | - | $214.36 M(-10.7%) |
| Mar 2013 | - | $240.11 M(+91.2%) |
| Dec 2012 | $161.96 M(+24.7%) | $125.56 M(-46.8%) |
| Sept 2012 | - | $235.93 M(-1.8%) |
| June 2012 | - | $240.34 M(+15.3%) |
| Mar 2012 | - | $208.54 M(+37.2%) |
| Dec 2011 | $129.89 M(-6.6%) | $152.03 M(-15.5%) |
| Sept 2011 | - | $179.96 M(-19.8%) |
| June 2011 | - | $224.33 M(-10.5%) |
| Mar 2011 | - | $250.71 M(-1.3%) |
| Dec 2010 | $139.13 M(-25.9%) | $254.14 M(+3.9%) |
| Sept 2010 | - | $244.62 M(-10.6%) |
| June 2010 | - | $273.51 M(+0.1%) |
| Mar 2010 | - | $273.31 M(-6.9%) |
| Dec 2009 | $187.85 M(+68.4%) | $293.53 M(+28.6%) |
| Sept 2009 | - | $228.16 M(-18.1%) |
| June 2009 | - | $278.42 M(-33.6%) |
| Mar 2009 | - | $419.34 M(-5.4%) |
| Dec 2008 | $111.55 M(+16.3%) | $443.12 M(-1.9%) |
| Sept 2008 | - | $451.78 M(-18.0%) |
| June 2008 | - | $550.63 M(+20.9%) |
| Mar 2008 | - | $455.48 M(+14.5%) |
| Dec 2007 | $95.89 M(+456.8%) | $397.90 M(-16.7%) |
| Sept 2007 | - | $477.63 M(+136.5%) |
| June 2007 | - | $201.96 M(-3.8%) |
| Mar 2007 | - | $209.92 M(-5.8%) |
| Dec 2006 | $17.22 M(+8.1%) | $222.78 M(+75.7%) |
| Sept 2006 | - | $126.83 M(-1.7%) |
| June 2006 | - | $129.06 M(-5.9%) |
| Mar 2006 | - | $137.12 M(+66.4%) |
| Dec 2005 | $15.93 M(-11.1%) | $82.41 M(+208.7%) |
| Sept 2005 | - | $26.70 M(-21.1%) |
| June 2005 | - | $33.84 M(-18.3%) |
| Mar 2005 | - | $41.44 M(-14.0%) |
| Dec 2004 | $17.93 M(+63.1%) | $48.18 M(+2.1%) |
| Sept 2004 | - | $47.20 M(-6.6%) |
| June 2004 | - | $50.51 M(+123.6%) |
| Mar 2004 | - | $22.59 M(-6.6%) |
| Dec 2003 | $10.99 M(+1757.1%) | $24.19 M |
| Dec 2002 | $592.00 K | - |
FAQ
- What is Alnylam Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual current assets year-on-year change?
- What is Alnylam Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly current assets year-on-year change?
What is Alnylam Pharmaceuticals annual total current assets?
The current annual current assets of ALNY is $2.98 B
What is the all time high annual current assets for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual total current assets is $2.98 B
What is Alnylam Pharmaceuticals annual current assets year-on-year change?
Over the past year, ALNY annual total current assets has changed by +$290.45 M (+10.79%)
What is Alnylam Pharmaceuticals quarterly total current assets?
The current quarterly current assets of ALNY is $3.36 B
What is the all time high quarterly current assets for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly total current assets is $3.36 B
What is Alnylam Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, ALNY quarterly total current assets has changed by +$369.97 M (+12.39%)